85426-5
Meropenem [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)
Active
Part Descriptions
LP17167-5 Meropenem
Meropenem is an ultra-broad spectrum antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta-lactam and belongs to the subgroup carbapenem. Meropenem was developed by Sumitomo Pharmaceuticals. It is marketed outside Japan by AstraZeneca under the brand names Merrem® and Meronem®. Unlike imipenem, it is not affected by the renal dehydrogenase and can therefore be given without cilastatin. It penetrates into the cerebrospinal fluid. Meropenem is less likely to cause seizures compared to imipenem.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Meropenem (Wikipedia)
LP234793-0 Isolate.meningitis
Various agencies, including the FDA and CLSI in the U.S. and EUCAST in Europe, publish guidelines for determining susceptibility of different organisms to different antimicrobials. In most cases, susceptibility does not vary by infection site, but for a few specific types of infection, including meningitis, pneumonia and urinary tract infection, certain antimicrobials have different susceptibility thresholds, which are called "breakpoints". For terms in LOINC that represent specific breakpoints, the LOINC System will indicate the type of infection that the breakpoint is based on, for example, Isolate.meningitis, Isolate.pneumonia, and Isolate.UTI.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Meropenem
- Property
- Susc
- Time
- Pt
- System
- Isolate.meningitis
- Scale
- OrdQn
- Method
- MIC
Additional Names
- Short Name
- Meropenem Islt.mening MIC
- Display Name
- Meropenem MIC (Isolate.meningitis) [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Meropenem
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.61
- Last Updated
- Version 2.61
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
50545-3 | Bacterial susceptibility panel by Minimum inhibitory concentration (MIC) |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-DE | German (Germany) | Meropenem: |
es-ES | Spanish (Spain) | Meropenem: |
es-MX | Spanish (Mexico) | Meropenem: |
fr-CA | French (Canada) | Méropénem: |
fr-FR | French (France) | Méropénème: |
it-IT | Italian (Italy) | Meropenem: Synonyms: Concentrazione minima inibitoria Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici |
nl-NL | Dutch (Netherlands) | meropenem: Synonyms: MIC |
zh-CN | Chinese (China) | 美罗培南: Synonyms: 分离株.脑膜炎(脑脊膜炎) 分离物; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=85426-5
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright